Aurigene Pharmaceutical Services Ltd., a subsidiary of Dr Reddy’s Laboratories, has launched Aurigene. AI, an innovative platform integrating artificial intelligence (AI) and machine learning (ML).

The platform is aimed at expediting drug discovery projects from hit identification to candidate nomination, Aurigene. AI harnesses AI and ML alongside Aurigene's expertise in synthesizing and testing molecules.

This groundbreaking platform features a meticulously curated database serving as robust training data. It offers users flexibility by presenting a range of AI models, including generative, predictive, and computational algorithms. Employing an iterative ML approach, Aurigene.AI enables rational chemical design and prioritization based on factors such as ADME properties and potency.

Aurigene.AI brings together advanced physics-based simulation, generative and predictive AI models, and computer-aided drug design (CADD) under one roof. The platform boasts a comprehensive database comprising 180 million compounds and 1.6 million validated bioassay data points, continually expanding to enrich the training data. Hosted on Google Cloud, Aurigene.AI ensures scalability and data security for seamless operations.

The integration of AI and ML capabilities with Aurigene's core competencies promises accelerated development of novel therapeutics. A recent case study validated the efficacy of Aurigene.AI, demonstrating a remarkable 35 percent reduction in cycle time from chemical design to synthesis and testing.

Akhil Ravi, CEO of Aurigene Pharmaceutical Services Ltd., expresses enthusiasm for advancing service experience and delivering innovative solutions. Aurigene.AI, he asserts, represents a data-driven approach to therapeutic development, enhancing the company's small-molecule discovery offering.

Dr. Gayathri Ramaswamy, Global Head of Discovery Services at Aurigene Pharmaceutical Services Ltd., emphasises the platform's potential to streamline the drug discovery process. By integrating AI and ML capabilities with core scientific expertise, Aurigene.AI stands poised to drive efficiency in identifying drug candidates.